Literature DB >> 10652307

Regulation of vascular smooth muscle tone by N-terminal region of caldesmon. Possible role of tethering actin to myosin.

Y H Lee1, C Gallant, H Guo, Y Li, C A Wang, K G Morgan.   

Abstract

To assess the functional significance of tethering actin to myosin by caldesmon in the regulation of smooth muscle contraction, we investigated the effects of synthetic peptides, containing the myosin-binding sequences in the N-terminal region of caldesmon, on force directly recorded from single permeabilized smooth muscle cells of ferret portal vein. Two peptides were used, IK29C and MY27C, containing residues from Ile(25) to Lys(53) and from Met(1) to Tyr(27) of the human and chicken caldesmon sequence, respectively, plus an added cysteine at the C terminus. In cells clamped at pCa 6. 7, both peptides increased basal tone. Pretreatment of cells at pCa 6.7 with IK29C or MY27C decreased the amplitude of subsequent phenylephrine-induced contractions but not microcystin-racemic mixture-induced contractions. In all cases the effects of the peptides were concentration-dependent, and IK29C was more potent than MY27C, in agreement with their relative affinity toward myosin. The peptides were ineffective after the phenylephrine contraction was established. MY27C did not further increase the magnitude of contraction caused by a maximally effective concentration of IK29C, consistent with the two peptides having the same mechanism of action. Neither polylysine nor two control peptides containing scrambled sequences of IK29C, which do not bind myosin, had any effect on basal or phenylephrine-induced force. Our results suggest that IK29C and MY27C induce contraction by competing with the myosin-binding domain of endogenous caldesmon. Digital imaging of fluoroisothiocyanate-tagged IK29C confirmed the association of the peptide with intracellular filamentous structures. The results are consistent with a model whereby tethering of actin to myosin by caldesmon may play a role in regulating vascular tone by positioning the C-terminal domain of caldesmon so that it is capable of blocking the actomyosin interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652307     DOI: 10.1074/jbc.275.5.3213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Smooth muscle caldesmon modulates peristalsis in the wild type and non-innervated zebrafish intestine.

Authors:  J Abrams; G Davuluri; C Seiler; M Pack
Journal:  Neurogastroenterol Motil       Date:  2012-03       Impact factor: 3.598

2.  Regulation of the crossbridge cycle in vascular smooth muscle by cAMP signalling.

Authors:  G Pfitzer; L T Lubomirov; K Reimann; H Gagov; R Schubert
Journal:  J Muscle Res Cell Motil       Date:  2006-08-24       Impact factor: 2.698

Review 3.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.

Authors:  Arda Cetinkaya; Jingwei Rachel Xiong; İbrahim Vargel; Kemal Kösemehmetoğlu; Halil İbrahim Canter; Ömer Faruk Gerdan; Nicola Longo; Ahmad Alzahrani; Mireia Perez Camps; Ekim Zihni Taskiran; Simone Laupheimer; Lorenzo D Botto; Eeswari Paramalingam; Zeliha Gormez; Elif Uz; Bayram Yuksel; Şevket Ruacan; Mahmut Şamil Sağıroğlu; Tokiharu Takahashi; Bruno Reversade; Nurten Ayse Akarsu
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

5.  Fatty Acyl Incorporation in the Biosynthesis of WAP-8294A, a Group of Potent Anti-MRSA Cyclic Lipodepsipeptides.

Authors:  Haotong Chen; Andrew S Olson; Wei Su; Patrick H Dussault; Liangcheng Du
Journal:  RSC Adv       Date:  2015-12-09       Impact factor: 3.361

6.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

Review 7.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

8.  Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.

Authors:  Ying-Ming Liou; Chu-Lung Chan; Renjian Huang; Chih-Lueh A Wang
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

9.  Amino acid mutations in the caldesmon COOH-terminal functional domain increase force generation in bladder smooth muscle.

Authors:  Maoxian Deng; Ettickan Boopathi; Joseph A Hypolite; Tobias Raabe; Shaohua Chang; Stephen Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

10.  Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon.

Authors:  Erik Y Zhang; Raimund Stein; Shaohua Chang; Yongmu Zheng; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.